MX2009010320A - Regimen anticonceptivo oral. - Google Patents

Regimen anticonceptivo oral.

Info

Publication number
MX2009010320A
MX2009010320A MX2009010320A MX2009010320A MX2009010320A MX 2009010320 A MX2009010320 A MX 2009010320A MX 2009010320 A MX2009010320 A MX 2009010320A MX 2009010320 A MX2009010320 A MX 2009010320A MX 2009010320 A MX2009010320 A MX 2009010320A
Authority
MX
Mexico
Prior art keywords
oral contraceptive
contraceptive regimen
human female
days
regimen
Prior art date
Application number
MX2009010320A
Other languages
English (en)
Inventor
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of MX2009010320A publication Critical patent/MX2009010320A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Abstract

Un método para lograr la anticoncepción en una mujer, que consiste en administrar oralmente a la mujer una composición que comprende 1.5 mg de 17-beta-estradiol y 2.5 mg de acetato de nomegestrol durante 24 días, seguido de un período libre de hormonas de 4 días.
MX2009010320A 2007-03-26 2008-03-26 Regimen anticonceptivo oral. MX2009010320A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92032607P 2007-03-26 2007-03-26
PCT/EP2008/053546 WO2008116873A1 (en) 2007-03-26 2008-03-26 Oral contraceptive regimen

Publications (1)

Publication Number Publication Date
MX2009010320A true MX2009010320A (es) 2010-01-20

Family

ID=39672648

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010320A MX2009010320A (es) 2007-03-26 2008-03-26 Regimen anticonceptivo oral.

Country Status (10)

Country Link
US (1) US20080242650A1 (es)
AR (1) AR065816A1 (es)
AU (1) AU2008231744A1 (es)
BR (1) BRPI0809089A2 (es)
CA (1) CA2682049A1 (es)
CL (1) CL2008000866A1 (es)
MX (1) MX2009010320A (es)
PE (1) PE20081895A1 (es)
TW (1) TWI472332B (es)
WO (1) WO2008116873A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
US9192614B2 (en) 2008-10-08 2015-11-24 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
US9198919B2 (en) 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
US9198876B2 (en) 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
US9198920B2 (en) 2009-03-27 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3079659B1 (en) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
JPS61243059A (ja) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5674863A (en) * 1991-10-18 1997-10-07 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US7494987B2 (en) * 2002-11-25 2009-02-24 Mochida Pharmaceutical Co., Ltd. Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient

Also Published As

Publication number Publication date
BRPI0809089A2 (pt) 2014-09-09
AU2008231744A1 (en) 2008-10-02
TW200902031A (en) 2009-01-16
TWI472332B (zh) 2015-02-11
CL2008000866A1 (es) 2008-10-03
AR065816A1 (es) 2009-07-01
US20080242650A1 (en) 2008-10-02
PE20081895A1 (es) 2009-01-26
CA2682049A1 (en) 2008-10-02
WO2008116873A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
MX2009010320A (es) Regimen anticonceptivo oral.
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
TW200621317A (en) Pharmaceutical composition
EP2364144A4 (en) PHARMACEUTICAL FORM FOR ADMINISTRATION THROUGH THE MOUTH
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
MX2009004179A (es) Uso de valerato de estradiol o 17?-estradiol en combinacion con dienogest en una terapia oral para mantener y/o incrementar la libido femenina.
CO6251259A2 (es) Formulaciones farmaceuticas de estriol en baja dosis
MX2007013137A (es) Regimen anticonceptivo con dosificacion de estrogeno ampliada.
WO2009020561A3 (en) Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extract thereof in combination with a steroid
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
WO2006072940A3 (en) Controlled long acting release pharmaceutical preparation for use in the oral cavity
AR049197A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
PH12020551911A1 (en) Use of riluzole oral disintigrating tablets for treating diseases
MX2021001563A (es) Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades.
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
AR049196A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
WO2006100595A3 (en) Chewing gum compositions of varenicline
MXPA06003678A (es) Metodos y estuches para mejorar la capacidad de aprender en un cachorro de perro o cachorro de gato.
UA102111C2 (uk) Фармацевтична композиція у вигляді разової пероральної дози, що містить леводопу, карбідопу і ентакапон або їх солі
TH140346A (th) แผนกำหนดของยากินคุมกำเนิด
HK1083199A1 (en) A pharmaceutical composition for use in the prevention and/or treatment of the oral cavity diseases caused by microorganisms
WO2009049813A3 (de) Verfahren zur herstellung eines einphasischen pharmazeutischen präparates zur begrenzung/minderung des risikos einer tiefen-venen-thrombose in einheit mit einer oralen kontrazeption
UA101370C2 (ru) Пероральные составы, которые содержат аналоги цитидина, и способы их использования

Legal Events

Date Code Title Description
FA Abandonment or withdrawal